|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0956 - 0.1061|
|52 Week Range||0.0100 - 0.1190|
|Beta (5Y Monthly)||2.94|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, BC / ACCESSWIRE / August 4, 2020 / NeutriSci International Inc.
VANCOUVER, BC, July 16, 2020 /CNW/ - Trading resumes in: Company: NeutriSci International Inc.
VANCOUVER, BC / ACCESSWIRE / July 16, 2020 / NeutriSci International Inc. ("NeutriSci" or the "Company") (NU.V)(NRXCF)(1N9.F), an innovative technology company developing products for the nutraceutical industry, is very pleased to provide a further update regarding its entry into the promising Japanese CBD market. NeutriSci has entered into a definitive agreement (the "Agreement"), dated July 9, 2020, with Tabletz LLC, its partner in Japan. The Agreement, which covers an initial period of five years and is renewable for further consecutive five year periods, provides Tabletz LLC with exclusivity to distribute and sell a new broad-spectrum hemp product line of quick melting sublingual CBD tabs ("Tabletz") in the Japanese market.